BackDianthus Therapeutics Overview
Dianthus Therapeutics Inc

Dianthus Therapeutics Target Price

Where could DNTH trade next? Consensus target price: $120.

Get informed when a big investor buys or sells

+ Follow

Share Price

$110.4

Average Target Price

$118.757.6% upside

4 analysts in the last 4 months

High: $132 | Low: $98

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-10Jefferies$13219.6% upsideOpen
2026-05-11Evercore ISIGavin Clark-Gartner$1208.7% upsideOpen
2026-05-06Raymond James$12513.2% upsideOpen
2026-04-08Wolfe ResearchAndy Chen$9811.2% downsideOpen
2026-03-09UBSMaury Raycroft$9811.2% downsideOpen
2026-03-09JefferiesMaury Raycroft$9811.2% downsideOpen
2026-03-09Robert W. Baird$13219.6% upsideOpen
2026-03-09H.C. WainwrightSwayampakula Ramakanth$13017.8% upsideOpen
2026-03-09OppenheimerTrevor Allred$14531.3% upsideOpen
2026-03-09Stifel NicolausAlex Thompson$1208.7% upsideOpen
2026-03-09Truist Financial$1100.4% downsideOpen
2026-02-11Wedbush$5550.2% downsideOpen
2026-01-29UBS$12513.2% upsideOpen
2026-01-08Truist Financial$6342.9% downsideOpen
2025-11-06OppenheimerTrevor Allred$6243.8% downsideOpen
2025-10-14Truist FinancialDanielle Brill$5649.3% downsideOpen
2025-09-08GuggenheimYatin Suneja$1009.4% downsideOpen
2025-09-08JefferiesMaury Raycroft$5153.8% downsideOpen
2024-11-11OppenheimerLeland Gershell$5252.9% downsideOpen
2024-04-18Raymond JamesSteven Seedhouse$5153.8% downsideOpen

Dianthus Therapeutics (DNTH) FAQ

Dianthus Therapeutics (DNTH) currently reports a target price of $120. Use the charts on this page to explore Dianthus Therapeutics's target price history and peer comparisons.

Analysts' average 12-month price target for Dianthus Therapeutics is $120, about 7.6% upside from the current share price of $110.4. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $120, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Dianthus Therapeutics, and consider following DNTH for alerts when major investors trade the stock.

Dianthus Therapeutics is classified in the Healthcare sector. On target price, it currently shows $120. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DNTH with unrelated industries.